| |
| |
|
| Insider
Information: |
Peacock Jonathan M |
| Relationship: |
Director |
| City: |
Thousand Oaks |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
446,071 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$34,332,237 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
446,071 |
|
|
| Total
Value |
$34,332,237 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
EVP & CFO |
2013-10-28 |
94,414 |
2010-10-28 |
0 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
Director |
2017-10-03 |
0 |
2014-06-25 |
0 |
Premium* |
|
|
Bellerophon Therapeutics Inc |
BLPH |
|
2021-03-31 |
157,033 |
|
0 |
Premium* |
|
|
Avantor, Inc. |
AVTR |
Director |
2024-05-09 |
194,624 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMGN |
Amgen Inc |
CFO |
• – – |
2010-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
CFO |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,800 |
115,800 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• – – |
2011-10-28 |
4 |
D |
$58.06 |
$605,392 |
D/D |
(10,427) |
105,373 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• – – |
2012-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,654 |
114,027 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2012-10-28 |
4 |
D |
$87.63 |
$1,022,730 |
D/D |
(11,671) |
102,438 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2013-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,477 |
109,950 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2013-04-25 |
4 |
D |
$104.93 |
$285,515 |
D/D |
(2,721) |
107,312 |
0 |
- |
|
| AMGN |
Amgen Inc |
EVP & CFO |
• • – |
2013-10-28 |
4 |
D |
$116.32 |
$1,517,394 |
D/D |
(13,045) |
94,414 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2014-06-25 |
4 |
A |
$15.30 |
$1,010,014 |
D/D |
66,014 |
66,014 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEOOfficer |
• • – |
2015-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
67 |
|
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2015-02-19 |
4 |
B |
$12.00 |
$249,600 |
D/D |
20,800 |
20,867 |
2.81 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2015-05-20 |
4 |
B |
$8.69 |
$48,323 |
D/D |
5,560 |
26,427 |
2.81 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2015-08-19 |
4 |
B |
$5.48 |
$27,377 |
D/D |
5,000 |
31,427 |
2.81 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2015-12-15 |
4 |
B |
$2.72 |
$20,400 |
D/D |
7,500 |
38,927 |
2.81 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2015-12-16 |
4 |
B |
$2.76 |
$35,336 |
D/D |
12,800 |
51,727 |
2.81 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2016-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
165,975 |
217,702 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
President and CEO |
• • – |
2016-05-17 |
4 |
B |
$1.37 |
$6,842 |
D/D |
5,000 |
222,702 |
2.81 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,950 |
67,964 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2016-11-29 |
4 |
B |
$0.00 |
$0 |
D/D |
285,715 |
508,417 |
2.31 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,410 |
70,374 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2017-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
57,972 |
566,389 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-09-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
635 |
69,739 |
0 |
- |
|
| BLPH |
Bellerophon Therapeutics ... |
Director |
– • – |
2017-09-29 |
4 |
B |
$0.00 |
$0 |
D/D |
248,962 |
815,351 |
2.31 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$180.00 |
$12,227,760 |
D/D |
(67,932) |
1,807 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
Director |
– • – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,807) |
0 |
0 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
